STAINES-UPON-THAMES, United Kingdom, May 27, 2020 – Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced that its Specialty Generics Division is expanding its hand sanitizer donations to Opioid Treatment Programs (OTPs) throughout the US.
Mallinckrodt Specialty Generics is manufacturing and donating hand sanitizer to all OTPs in support of its uninterrupted care of opioid use disorder patients during the COVID-19 pandemic. The donated sanitizer is immediately available for orders by all OTPs, irrespective of whether the programs are Mallinckrodt customers. All production and shipping costs of the hand sanitizer are absorbed by Mallinckrodt.
“Understanding that the outbreak of COVID-19 would result in high demand and short supply of hand sanitizer, Mallinckrodt proactively converted an active pharmaceutical ingredient (API) manufacturing line to produce hand sanitizer in order to protect both our essential workers as well as people in the communities we serve. We are proud to be expanding our sanitizer donation program to all OTPs, whose continuous treatment and care for those struggling with addiction has never been more challenging or essential,” said Spiro Gavaris, president of Mallinckrodt Specialty Generics.
In addition, Mallinckrodt Specialty Generics is donating hand sanitizer to emergency management operations located in regions in which it operates. The emergency management operations are distributing the sanitizer to public health and safety agencies. On a weekly basis, Mallinckrodt’s St. Louis plant is manufacturing over 900 gallons of sanitizers for donation.
"As the pandemic started and we scaled up production of hand sanitizer for all of our manufacturing sites, it became clear that frontline providers had a critical need that our St. Louis plant could help fill,” said John Leonard, senior director, manufacturing, Specialty Generics. “It has been a true team effort to make the hand sanitizer available to those who need it the most during the current shortages.”
Hand sanitizer donations are available in cases of four 1-gallon containers. All OTPs may order sanitizer by emailing the following information: [OTP name, Email, Phone, Address, Number of cases] to Sanitizer@mnk.com.
Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market, and distribute specialty pharmaceutical products and therapies. The company's Specialty Brands reportable segment's areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; analgesics and gastrointestinal products. Its Specialty Generics reportable segment includes specialty generic drugs and active pharmaceutical ingredients. To learn more about Mallinckrodt, visit www.mallinckrodt.com.
Please note Mallinckrodt has requested expedited guidance from the U.S. Department and Health and Human Services, Office of Inspector General (OIG) regarding the donation of sanitizer to OTPs and its legality under the federal Anti-Kickback Statute (42 USC 1320a-7b). OTP and Mallinckrodt agree that (i) Mallinckrodt’s provision of hand and surface sanitizer imposes no obligation, express or implied, on OTP to purchase or prescribe, or recommend or arrange for the purchase or prescription of, Mallinckrodt’s products or services, nor does the provision of hand and surface sanitizer represent remuneration for any past or future use or purchase of Mallinckrodt’s products or services; and (ii) the provision of hand and surface sanitizer is not in exchange for, and does not take into account, the volume or value of referrals or other business generated, if any, by OTP. If Mallinckrodt was to receive guidance from the OIG that necessitates the termination of the donations, we will immediately discontinue our donations.
For OTP Inquiries
Mallinckrodt, the “M” brand mark and the Mallinckrodt Pharmaceuticals logo are trademarks of a Mallinckrodt company. Other brands are trademarks of a Mallinckrodt company or their respective owners. © 2019 Mallinckrodt. 9/19